Public Health England   Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: London United Kingdom (2013)

Organization Overview

First Clinical Trial
2013
NCT00197769
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dr. Elizabeth Miller | Prof. Elizabeth Miller | Public Health England

Active Ingredients

Drugs in Phase 4 Trials (21)

10-valent Pneumococcal Conjugate Vaccine (Pneumosil) (1 trial)

azithromycin (zithromax) (2 trials)

clindamycin (cleocin) (1 trial)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (2 trials)

diphtheria, tetanus and whole cell pertussis vaccine (Boostrix) (1 trial)

fluarix (1 trial)

flucloxacillin (1 trial)

haemophilus influenzae type b conjugate vaccine (HibTITER) (2 trials)

hpv 16/18 vaccine (Cervarix) (1 trial)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)

inactivated influenza vaccine (7 trials)

Inactivated polio virus - Enhanced (IPOL) (2 trials)

live attenuated influenza virus vaccine (Flumist) (4 trials)

Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi) (2 trials)

menitorix (2 trials)

menjugate (2 trials)

Monovalent group C meningococcal vaccine (Menomune-C) (2 trials)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135) (3 trials)

serogroup B meningococcal vaccine (Bexsero) (5 trials)

technetium tc-99m pentetate kit (renotec) (1 trial)

Drugs in Phase 3 Trials (5)

ad26.zebov (Zabdeno) (1 trial)

human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)

menafrivac (1 trial)

mva-bn-filo (Mvabea) (1 trial)

s. aureus type 5 & 8 capsular polysaccharide conjugate (1 trial)

Drugs in Phase 2 Trials (9)

9 valent pneumococcal conjugate vaccine (1 trial)

acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (1 trial)

aflunov (1 trial)

measles, mumps, and rubella vaccine (MMR) (1 trial)

menc-hib (1 trial)

multi-valent pneumococcal conjugate vaccine (1 trial)

omv (1 trial)

pneumococcal 7-valent conjugate vaccine (Prevnar) (1 trial)

serogroup b meningococcal vaccine (Trumenba) (1 trial)

Drugs in Phase 1 Trials (2)

desflurane (suprane) (1 trial)

potassium alum (1 trial)

Drugs in Other Trials (1)

neisseria lactamica (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Cellulitis (Phase 4)

Communicable Diseases (Phase 4)

Diphtheria (Phase 4)

Egg Hypersensitivity (Phase 4)

Hemorrhagic Fever, Ebola (Phase 3)

Hepatitis (Phase 4)

Hepatitis B (Phase 4)

Hypersensitivity (Phase 4)

Infections (Phase 4)

Influenza, Human (Phase 4)

Meningitis (Phase 4)

Meningitis, Meningococcal (Phase 3)

Meningococcal Infections (Phase 4)

Papillomavirus Infections (Phase 4)

Pneumococcal Infections (Phase 4)

Pneumonia (Phase 2)

Premature Birth (Phase 4)

Staphylococcal Infections (Phase 3)

Virus Diseases (Phase 3)

Whooping Cough (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 39
  • # of Trial APIs: 38